HORIZON HEALTH INTERNATIONAL CORP. (PINK SHEETS:HZHI) (The Company) is pleased to announce that it has executed a Definitive Agreement with Exmovere Holdings Inc. of McLean, Virginia USA (Exmovere). Under the terms of the Agreement Horizon will pay Exmovere a total of two million dollars over a one year period for the exclusive rights to market and distribute their products in Canada for a 15 year term.
"EXMOVERE" owns and controls the global rights to certain Products, specifically the Telepath Zigbee biosensor wristwatch and the Chariot personal mobility device (the 'Products'). The 'Products' can be viewed at www.exmovere.com or, through the Horizon website at www.horizonhealthandsafety.com. Both products will be available in spring of 2010.
The Exmovere "Chariot" is a mobility device that can be implemented by millions of people suffering from mobility problems. The Chariot has several competitive advantages. It is the only, truly hands free, self-balancing vehicle. It also serves as a unique platform for integrating vital sign, emotion monitoring and environmental sensors for hospitals, military and hazardous materials workers. It is a new wearable device that will help people with physical challenges to get around.
Exmovere controls the world's first and only Zigbee biosensor wristwatch, called the 'Telepath', that uses infrared sensors to detect heart rate without a chest strap, 3-d accelerometers to model human movement, and a variety of metallic sensors to detect skin temperature and skin conductance. The 'Telepath' transmits these data via computer or cell phone to online data centers, care givers and/or emergency services.
HORIZON HEALTH INTERNATIONAL CORP